133 related articles for article (PubMed ID: 34335929)
1. BZW2/5MP1 acts as a promising target in hepatocellular carcinoma.
Li G; Lu A; Chen A; Geng S; Xu Y; Chen X; Yang J
J Cancer; 2021; 12(17):5125-5135. PubMed ID: 34335929
[TBL] [Abstract][Full Text] [Related]
2. Role of the novel gene BZW2 in the development of hepatocellular carcinoma.
Jin X; Liao M; Zhang L; Yang M; Zhao J
J Cell Physiol; 2019 Sep; 234(9):16592-16600. PubMed ID: 30805927
[TBL] [Abstract][Full Text] [Related]
3. BZW2 promotes the malignant progression of colorectal cancer via activating the ERK/MAPK pathway.
Huang L; Chen S; Fan H; Ai F; Sheng W
J Cell Physiol; 2020 May; 235(5):4834-4842. PubMed ID: 31643092
[TBL] [Abstract][Full Text] [Related]
4. Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer.
Sato K; Masuda T; Hu Q; Tobo T; Gillaspie S; Niida A; Thornton M; Kuroda Y; Eguchi H; Nakagawa T; Asano K; Mimori K
EBioMedicine; 2019 Jun; 44():387-402. PubMed ID: 31175057
[TBL] [Abstract][Full Text] [Related]
5. BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle-invasive bladder cancers: A microarray pathway analysis.
Gao H; Yu G; Zhang X; Yu S; Sun Y; Li Y
J Cell Mol Med; 2019 Jun; 23(6):3905-3915. PubMed ID: 30932331
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of BZW2 expression in lung adenocarcinoma patients.
Wang S; Bai W; Huang J; Lv F; Bai H
Int J Clin Exp Pathol; 2019; 12(12):4289-4296. PubMed ID: 31933829
[TBL] [Abstract][Full Text] [Related]
7. Promotion of BZW2 by LINC00174 through miR-4500 inhibition enhances proliferation and apoptosis evasion in laryngeal papilloma.
Liu J; Yang T; Zhang Y; Wang S
Cancer Cell Int; 2020; 20():471. PubMed ID: 33005104
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of BZW2 inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway.
Cheng DD; Li SJ; Zhu B; Yuan T; Yang QC; Fan CY
Oncol Rep; 2017 Oct; 38(4):2116-2122. PubMed ID: 28791373
[TBL] [Abstract][Full Text] [Related]
9. BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β.
Jin K; Li Y; Wei R; Liu Y; Wang S; Tian H
Cell Death Discov; 2024 Feb; 10(1):105. PubMed ID: 38424042
[TBL] [Abstract][Full Text] [Related]
10. Translational autoregulation of BZW1 and BZW2 expression by modulating the stringency of start codon selection.
Loughran G; Firth AE; Atkins JF; Ivanov IP
PLoS One; 2018; 13(2):e0192648. PubMed ID: 29470543
[TBL] [Abstract][Full Text] [Related]
11. Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma.
Ge J; Mu S; Xiao E; Tian G; Tao L; Li D
Front Genet; 2022; 13():1002673. PubMed ID: 36267402
[No Abstract] [Full Text] [Related]
12. Interactome Analysis Identifies the Role of BZW2 in Promoting Endoplasmic Reticulum-Mitochondria Contact and Mitochondrial Metabolism.
Maio G; Smith M; Bhawal R; Zhang S; Baskin JM; Li J; Lin H
Mol Cell Proteomics; 2024 Feb; 23(2):100709. PubMed ID: 38154691
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
14. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
15. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
17. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
19. The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.
Steinway SN; Dang H; You H; Rountree CB; Ding W
PLoS One; 2015; 10(5):e0128159. PubMed ID: 26000702
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
